Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Feb 26

PMID 33633722

Citations 3

Authors

Matthias Hubenthal

Britt-Sabina Loscher

Jeanette Erdmann

Andre Franke

Damian Gola

Inke R Konig

Hila Emmert

Affiliations

Soon will be listed here.

Abstract

In this mini-review, we highlight selected research by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Precision Medicine in Chronic Inflammation" focusing on clinical sequencing and the clinical utility of polygenic risk scores as well as its implication on precision medicine in the field of the inflammatory diseases inflammatory bowel disease, atopic dermatitis and coronary artery disease. Additionally, we highlight current developments and discuss challenges to be faced in the future. Exemplary, we point to residual challenges in detecting disease-relevant variants resulting from difficulties in the interpretation of candidate variants and their potential interactions. While polygenic risk scores represent promising tools for the stratification of patient groups, currently, polygenic risk scores are not accurate enough for clinical setting. Precision medicine, incorporating additional data from genomics, transcriptomics and proteomics experiments, may enable the identification of distinct disease pathogeneses. In the future, data-intensive biomedical innovation will hopefully lead to improved patient stratification for personalized medicine.

Citing Articles

Considerations in Paediatric and Adolescent Inflammatory Bowel Disease.

Vuijk S, Camman A, de Ridder L J Crohns Colitis. 2024; 18(Supplement_2):ii31-ii45.

PMID: 39475081 PMC: 11523044. DOI: 10.1093/ecco-jcc/jjae087.

A Polygenic Risk Analysis for Identifying Ulcerative Colitis Patients with European Ancestry.

Liu L, Wu Y, Li Y, Li M Genes (Basel). 2024; 15(6).

PMID: 38927620 PMC: 11202467. DOI: 10.3390/genes15060684.

The genetics of non-monogenic IBD.

Jans D, Cleynen I Hum Genet. 2023; 142(5):669-682.

PMID: 36720734 DOI: 10.1007/s00439-023-02521-9.

References

Weidinger S, Willis-Owen S, Kamatani Y, Baurecht H, Morar N, Liang L . A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet. 2013; 22(23):4841-56. PMC: 3820131. DOI: 10.1093/hmg/ddt317. View

Krarup N, Borglykke A, Allin K, Sandholt C, Justesen J, Andersson E . A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals. Atherosclerosis. 2015; 240(2):305-10. DOI: 10.1016/j.atherosclerosis.2015.03.022. View

Beaney K, Cooper J, Drenos F, Humphries S . Assessment of the clinical utility of adding common single nucleotide polymorphism genetic scores to classical risk factor algorithms in coronary heart disease risk prediction in UK men. Clin Chem Lab Med. 2017; 55(10):1605-1613. DOI: 10.1515/cclm-2016-0984. View

Jung E, Petersen B, Mayr G, Cheon J, Kang Y, Lee S . Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2018; 30(12):1491-1496. DOI: 10.1097/MEG.0000000000001247. View

Esparza-Gordillo J, Schaarschmidt H, Liang L, Cookson W, Bauerfeind A, Lee-Kirsch M . A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. J Allergy Clin Immunol. 2013; 132(2):371-7. DOI: 10.1016/j.jaci.2013.01.057. View

Lenz T, Deutsch A, Han B, Hu X, Okada Y, Eyre S . Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015; 47(9):1085-90. PMC: 4552599. DOI: 10.1038/ng.3379. View

Jostins L, Ripke S, Weersma R, Duerr R, McGovern D, Hui K . Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. PMC: 3491803. DOI: 10.1038/nature11582. View

Glocker E, Kotlarz D, Klein C, Shah N, Grimbacher B . IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci. 2012; 1246:102-7. DOI: 10.1111/j.1749-6632.2011.06339.x. View

Engelhardt K, Shah N, Faizura-Yeop I, Uygun D, Frede N, Muise A . Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2012; 131(3):825-30. DOI: 10.1016/j.jaci.2012.09.025. View

10.

Jansen P, Petrus N, Venema A, Posthuma D, Mannens M, Sprikkelman A . Higher Polygenetic Predisposition for Asthma in Cow's Milk Allergic Children. Nutrients. 2018; 10(11). PMC: 6266812. DOI: 10.3390/nu10111582. View

11.

Green R, Berg J, Grody W, Kalia S, Korf B, Martin C . ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013; 15(7):565-74. PMC: 3727274. DOI: 10.1038/gim.2013.73. View

12.

Paternoster L, Standl M, Waage J, Baurecht H, Hotze M, Strachan D . Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet. 2015; 47(12):1449-1456. PMC: 4753676. DOI: 10.1038/ng.3424. View

13.

Borg-Bartolo S, Boyapati R, Satsangi J, Kalla R . Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res. 2020; 9. PMC: 6993839. DOI: 10.12688/f1000research.20928.1. View

14.

Wollenberg A, Howell M, Guttman-Yassky E, Silverberg J, Kell C, Ranade K . Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb. J Allergy Clin Immunol. 2018; 143(1):135-141. DOI: 10.1016/j.jaci.2018.05.029. View

15.

Erdmann J, Kessler T, Venegas L, Schunkert H . A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res. 2018; 114(9):1241-1257. DOI: 10.1093/cvr/cvy084. View

16.

Marigorta U, Denson L, Hyams J, Mondal K, Prince J, Walters T . Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease. Nat Genet. 2017; 49(10):1517-1521. PMC: 5745037. DOI: 10.1038/ng.3936. View

17.

Liu J, van Sommeren S, Huang H, Ng S, Alberts R, Takahashi A . Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015; 47(9):979-986. PMC: 4881818. DOI: 10.1038/ng.3359. View

18.

Schicho R, Marsche G, Storr M . Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015; 16(3):181-8. PMC: 4366573. DOI: 10.2174/1389450116666150202161500. View

19.

Evans D, Spencer C, Pointon J, Su Z, Harvey D, Kochan G . Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011; 43(8):761-7. PMC: 3640413. DOI: 10.1038/ng.873. View

20.

Cleynen I, Boucher G, Jostins L, Schumm L, Zeissig S, Ahmad T . Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2015; 387(10014):156-67. PMC: 4714968. DOI: 10.1016/S0140-6736(15)00465-1. View